Pharmaceutical stocks rebounded slightly on Wednesday, with COVID-19 drugs leading the rise. The first one to pull up was Wuzhong, Jiangsu, with many small market capitalization concepts. Then Lahuahai Pharmaceuticals and medium and large market capitalization institutions can ta

2025/10/2121:56:35 finance 1298

Pharmaceutical stocks rebounded slightly on Wednesday, with COVID-19 drugs leading the rise. The first one to pull up was Jiangsu Wuzhong , which has many small market capitalization concepts. Later, Lahuahai Pharmaceutical and medium and large market capitalization institutions were able to take positions and . After these two stocks hit the daily limit of , they finally led to the rebound of Zhongsheng Pharmaceutical . The track was adjusted on Wednesday, medical care is popular, and the concept of oximeter is fermenting again. Lexin Medical and Kangtai Medical , which were raised last Friday, rose by +20% and +17.87% respectively. After Lexin Medical hit the daily limit, iPeng Medical closed the board with +20% assists in the afternoon.

The first listings of the two new coronavirus drugs and the 20 cm blood oximeter of the two companies are all hype based on the concept of the epidemic. Traditional Chinese medicines are basically getting A grades. COVID-19 medicines are worth looking forward to, and antipyretics are also getting A grades. Meinian Health, due to a professional physical examination, reached the daily limit on Tuesday, was even blocked on Wednesday, and was not blocked in the afternoon. The logic is that many people have strong concerns about whether there will be problems with the lungs after being exposed to the sun. This is the rising logic of Meinian Health.

The two cities generally fell, with stocks and stocks falling as high as 3,957, and only 969 stocks rising. In such an atmosphere, 10 stocks in the two cities were connected. This shows that the continuous market atmosphere has not been affected. As long as the comparison is strong, especially the 2-in-3 varieties, it is possible to achieve the daily limit. 2 into 3, the best ticket for model intervention should be Rifeng Shares. Except for the one-word board, ZTE Commercial was the first to hit the daily limit. Subsequently, the company with the highest increase was Rifeng Shares, followed by Xi'an Tourism and Xi'an Catering . All three companies were promoted to the three consecutive boards.

Infineon fell back on the 5 daily line in early trading. The time-sharing undertaking was very strong, and soon large funds began to rush for funds. 8,000 ignition orders appeared in the green disk. The market was obviously stronger than Business Bao . After Business Bao opened high and went low , the green disk was not as good as Infineon's undertaking. At 14:09 p.m., Infineon hit its daily limit, and at 14:12, Xi'an Food and Beverage hit its daily limit, Business Bao soared from +2% to +8% before falling back, and Black Sesame also hit its daily limit from +6.97%, but did not close. These are the demonstration effects of Infineon.

Pharmaceutical stocks rebounded slightly on Wednesday, with COVID-19 drugs leading the rise. The first one to pull up was Wuzhong, Jiangsu, with many small market capitalization concepts. Then Lahuahai Pharmaceuticals and medium and large market capitalization institutions can ta - DayDayNews

After Xi'an Tourism hit the daily limit in early trading, many companies were closed due to the recovery in consumption. Xiangyuan Culture, Jinyi Film and Television, Sunshine Dairy, Guifaxiang, etc. were hit by the limit. In the end, Jinyi Film and Television and Sunshine Dairy were blocked, and Guifaxiang's bad board was closed. The core of consumption is Xi'an Food, but it was Xi'an Tourism that took the lead on Wednesday. With these two stocks in the same city, Xi'an Tourism has gradually gotten rid of the influence of Xi'an Food, and has gone out of an independent rising market. In the field of consumption recovery, it is possible to replace Xi'an Food.

Pharmaceutical stocks rebounded slightly on Wednesday, with COVID-19 drugs leading the rise. The first one to pull up was Wuzhong, Jiangsu, with many small market capitalization concepts. Then Lahuahai Pharmaceuticals and medium and large market capitalization institutions can ta - DayDayNews

There were changes in power stocks on Wednesday, with green power concept hitting 3 limits. Among them, Jinshan shares were the first to hit the limit, which was the Dragon, Silver Star Energy and Jinko Technology closed the board, and Solar Energy and Guangyu Development exploded. Judging from the fried board, it is the process of the sector peaking and falling back. If the anti-packaging can be repaired on Thursday, green power is expected to continue to rebound, and the probability of Kingsoft's promotion will increase.

Let’s take a look at the decline list. Guanghong Holdings , Ruyi Group , Asia Star Bus and other dropped to the limit . When the continuous promotion is blocked, it is not a high-identification product and the bidding fails to become stronger. It should be dealt with in a timely manner. It cannot be a lucky mentality, which will lead to the expansion of losses. Anael once fell to the limit during the session, then climbed up in the afternoon, closing down -1.92%. Judging from the trend on Wednesday, Anael is more active than Yiyi Group, but it should be noted that if Anael opens sharply lower than on Thursday, there is a possibility of falling again.

Next, let’s take a look at the promotion status of the company, as shown in the picture below:

Pharmaceutical stocks rebounded slightly on Wednesday, with COVID-19 drugs leading the rise. The first one to pull up was Wuzhong, Jiangsu, with many small market capitalization concepts. Then Lahuahai Pharmaceuticals and medium and large market capitalization institutions can ta - DayDayNews

6 company: Maiquer

3 company: Guozhong Water Affairs , Rifeng Shares, Xi’an Tourism, Oujing Technology, ZTE Commercial, Xi’an Catering

2 connecting board: Dingjide, Longjian shares , Xinhualian

Maiquer continued to shrink and was promoted, but failed to explode in volume. The volume was postponed to Thursday, and the volume was reduced for three consecutive days. The stock price has strengthened significantly. It stands to reason that if the volume can be sustained, there is hope of becoming a monster.But in fact, if the explosive volume blocks the market on Thursday, Maiquer will move 3 feet, and there is a possibility of key JK after the market opens on Friday. Therefore, big funds should not block the market on Thursday. If the explosive volume falls back in the early trading, it is possible for Heli funds to push it up in the afternoon. It may become the form of Infineon on Tuesday or the Quanjude pattern of last Friday.

If Maiquer fails to advance, the height board will be reduced to 4 consecutive boards. In other words, the 6 3 consecutive boards promoted on Wednesday will create a high degree of competition. The new space dragon is among these 6 stocks. The 6 consecutive boards are the space on Wednesday. The six 3 consecutive boards will lead the rise, at least 5 consecutive boards. Therefore, those who advance from 2 to 3 on Wednesday may eat a lot of meat.

Guozhong Water Affairs is a one-word board promoted by good news. In fact, the participation degree is of little significance. Unless there is a channel to drain it, opening the board may be a good thing, because the good news is not big, and it just happens to be strong in the continuous board. Therefore, it can be avoided.

In addition to the one-line board of China Water Affairs, ZTE Commercial was the first to hit the limit. ZTE Commercial is 2 into 3 and is the strongest except for the one-line board. On Thursday, it is expected that will open sharply higher and will follow the second board, but there is also the risk of blowing up the board.

Rifeng Shares, in this wave of track stocks, Rifeng Shares and Oujing Technology have advanced to three consecutive boards. Judging from the upward trend and shape, Rifeng Shares’ promotion probability is much higher than Oujing Technology. Therefore, the best 2-to-3 on Wednesday is Rifeng Shares, and it may be the first to advance on Thursday.

Pharmaceutical stocks rebounded slightly on Wednesday, with COVID-19 drugs leading the rise. The first one to pull up was Wuzhong, Jiangsu, with many small market capitalization concepts. Then Lahuahai Pharmaceuticals and medium and large market capitalization institutions can ta - DayDayNews

Xi'an Tourism is second only to the daily limit of Rifeng Shares. After the daily limit, it has driven the recovery and increase in consumption. It should be said that it is the 2-in-3 that made the most profit from the bidding on Wednesday. Because the bidding was rushed at the end, the increase was relatively small, and then it rose rapidly. The increase instantly soared to the top three of the 13 2-link companies. This kind of back-row insertion reflects the time-sharing strength. The probability of promotion is higher on Thursday. Because of the shrinkage and sealing of the board, there is a risk of the board falling back. This should also be noted.

Xi'an Diet, on Wednesday, it followed Infineon to the daily limit. It has not beaten Xi'an Diet, not even Infineon, so there is a possibility of weakening. At present, it has entered the third wave in form, with the appearance of a New Year's Eve demon and high popularity. It can no longer be compared with the same level, and must be treated with the demon stock model. If you continue to hold on to the demon stock, you can continue to buy low. Once the undertaking is blown up and the instantaneous straight-line drop exceeds 7%, you must remain highly cautious. In the

2 list, Dingji won a straight line and may open on Thursday. Tianyang New Materials and Lvkang Biochemical with the same concept have both fallen behind. Therefore, Dingji has a higher probability of breaking the bar on Thursday. There is a risk of opening high and moving low, which can be avoided.

Longjian Shares, a beneficiary stock of the concept of rural revitalization on Tuesday, had a good news of Far East on Tuesday night, and on Wednesday it hit a one-word explosion and closed the volume. If this trend can open sharply higher on Thursday and the time-sharing trend does not fall rapidly, there is hope of advancement. If the bidding opens low or the increase is very small, it is necessary to avoid the risk of covering the decline.

Xinhualian, like Longjian Holdings, is a low-priced stock in the 3-yuan range. On Thursday, the two companies will compete for the opportunity to enter the 3-yuan range. In this wave of two consecutive boards, two of them are stocks in the 3-yuan range. Does this mean that there will be a wave of low-priced stocks? On Thursday, 1 enters 2. Do we need to consider the low-priced stocks? Jinshan shares on the first board are low-priced stocks priced at less than 3 yuan, and Zhongke Cloud Network are also low-priced stocks in the 4-yuan range. There is also a three-tiered Intermediate Water Company, which is also in the 3-yuan range. It is just a gap in chips. Will it be promoted because of the low price?

The key sector on Thursday has become 3 into 4. The main direction is to pay attention to the varieties of low-priced stocks. Low-priced stocks and small market capitalization often complement each other. Lexin Medical, which hit the daily limit on Wednesday, has a small market capitalization of more than 2 billion. It is speculating on the concept of blood oximeter. In fact, the company only produces smart wearable bracelets with blood oxygen detection functions. The concept is not very pure, but because of its small size, it was selected as the pioneer of 20 cm. If it can open significantly higher and the time-sharing will not fall back without acceptance, there may be hope for an upgrade.

Pharmaceutical stocks rebounded slightly on Wednesday, with COVID-19 drugs leading the rise. The first one to pull up was Wuzhong, Jiangsu, with many small market capitalization concepts. Then Lahuahai Pharmaceuticals and medium and large market capitalization institutions can ta - DayDayNews

finance Category Latest News